SEC Form 4 · accession 0001225208-15-016368

Merck & Co., Inc. · MRK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP & Chief Info Officer

Period of report

Jul 31, 2015

Accepted (ET)

Aug 4, 2015 · 2:41 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000310158

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 31, 2015	M	14,260	$39.29	A	22,712	D
Common Stock	Jul 31, 2015	M	8,085	$36.56	A	30,797	D
Common Stock	Jul 31, 2015	M	5,200	$44.30	A	35,997	D
Common Stock	Jul 31, 2015	M	3,120	$44.19	A	39,117	D
Common Stock	Jul 31, 2015	M	2,602	$33.49	A	41,719	D
Common Stock	Jul 31, 2015	M	2,275	$45.85	A	43,994	D
Common Stock	Jul 31, 2015	S	16	$58.98	D	43,978	D
Common Stock	Jul 31, 2015	S	838	$58.9759	D	43,140	D
Common Stock	Jul 31, 2015	S	912	$58.977	D	42,228	D
Common Stock^F1,F2	Jul 31, 2015	S	30,065	$59.0937	D	12,163	D
Common Stock - 401(k) Plan^F3	holding	—	—		—	8,951	I	By 401(k)

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (right to buy)^F4	$44.30	Jul 31, 2015	M	5,200	D	Feb 28, 2009	Feb 28, 2018	Common Stock	5,200	D
Stock Option (right to buy)^F5	$44.19	Jul 31, 2015	M	3,120	D	Mar 2, 2008	Mar 1, 2017	Common Stock	3,120	D
Stock Option (right to buy)^F6	$39.29	Jul 31, 2015	M	14,260	D	May 2, 2013	May 1, 2022	Common Stock	14,260	D
Stock Option (right to buy)^F7	$36.56	Jul 31, 2015	M	8,085	D	May 4, 2012	May 3, 2021	Common Stock	8,085	D
Stock Option (right to buy)^F8	$33.49	Jul 31, 2015	M	2,602	D	May 7, 2011	May 6, 2020	Common Stock	2,602	D
Stock Option (right to buy)^F9	$45.85	Jul 31, 2015	M	2,275	D	Nov 1, 2007	Oct 31, 2016	Common Stock	2,275	D

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.0600 to $59.1250, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
F2Since the date of the reporting person's last ownership report, Mr. Golestani transferred 953 shares of common stock of Merck & Co., Inc. to his former spouse pursuant to a domestic relations order. Holding also include shares acquired in dividend reinvestment transactions.
F3Includes shares acquired and dividends earned through July 8, 2015, in the Merck U.S. Savings Plan, a 401(k) plan.
F4The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.
F5The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010.
F6The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015.
F7The option became exercisable in equal installments on 5/4/2012, 5/4/2013, 5/4/2014.
F8The option became exercisable in equal installments on 5/7/2011, 5/7/2012 and 5/7/2013.
F9The option became exercisable in equal installments on 11/1/2007, 11/1/2008 and 11/1/2009.